Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5596 USD | +3.34% | -0.25% | -47.21% |
21/03 | Transcript : Ensysce Biosciences, Inc., Q4 2023 Earnings Call, Mar 21, 2024 | |
15/03 | Ensysce Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.21% | 4.11M | |
+20.87% | 47.02B | |
+49.56% | 41.86B | |
-0.03% | 41.76B | |
-4.27% | 28.8B | |
+11.71% | 26.05B | |
-21.57% | 19.15B | |
+4.06% | 12.55B | |
+28.08% | 12.34B | |
-4.54% | 11.82B |
- Stock Market
- Equities
- ENSC Stock
- News Ensysce Biosciences, Inc.
- Transcript : Ensysce Biosciences, Inc., Q4 2023 Earnings Call, Mar 21, 2024